Catalyst Biosciences Inc (NASDAQ:CBIO)

4.17
Delayed Data
As of May 14
 -0.12 / -2.80%
Today’s Change
4.05
Today|||52-Week Range
8.22
-33.91%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Biotechnology
MARKET CAP
$131.0M

Company Description

Catalyst Biosciences, Inc. is a clinical-stage biopharmaceutical company. It engages in the development of novel medicines to address serious medical conditions. The company was founded on March 7, 1997 and is headquartered in South San Francisco, CA.

Contact Information

Catalyst Biosciences, Inc.
611 Gateway Boulevard
South San Francisco California 94080
P:(650) 871-0761
Investor Relations:

Employees

Shareholders

Individual stakeholders6.32%
Other institutional46.20%
Mutual fund holders14.44%

Top Executives

Nassim UsmanPresident, Chief Executive Officer & Director
Clinton MusilChief Financial Officer
Howard LevyChief Medical Officer
Andrew HetheringtonSenior Vice President-Technical Operations
Linda NeumanVice President-Clinical Development